Two main methods have been proposed in relation to bladder ART ... 48% of patients received neoadjuvant or adjuvant radiotherapy and/or chemotherapy. § 24% of patients received postoperative ...

Platinum-based chemotherapy has long been the standard treatment for metastatic bladder cancer and for muscle-invasive ...

Standard treatment for muscle-invasive bladder cancer is neoadjuvant chemotherapy followed by ... Previous trials of neoadjuvant and adjuvant immunotherapy showed clinical benefit in this setting ...

Perioperative durvalumab has “the potential to transform the standard of care” for patients with muscle-invasive bladder ...

“We are disappointed in the ADJUVANT BR.31 results ... NIAGARA compared Imfinzi plus chemo to chemo alone in muscle-invasive bladder cancer (MIBC) patients scheduled for a cystectomy to ...

There are about 80,000 new cases of bladder cancer every year in the US alone ... This research has determined that ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced the completion of a study ...

A multigene signature can be used to guide decisions about adjuvant therapy in patients with triple-negative breast cancer, data suggest.

When John noticed blood in his urine, he consulted his doctor and was quickly referred to a urologist. (John is a composite character, based on the experiences of real-life patients.) John was ...

Pertuzumab (Perjeta) treats HER2-positive early breast cancer, usually in combination with trastuzumab and chemotherapy. It’s FDA-approved for neoadjuvant and adjuvant treatment. Neoadjuvant use ...